Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing
Ratna Sari Wijaya(University of Southampton), Sean H. Lim(University Hospital Southampton NHS Foundation Trust), Matthew J. Ahearne(University of Leicester), Marina Johnson, Victoria Willimott(Norfolk and Norwich University Hospitals NHS Foundation Trust), Nicola Campbell(Cancer Research UK), Andrew Davies(University Hospital Southampton NHS Foundation Trust), Tobias Menne(Newcastle upon Tyne Hospitals NHS Foundation Trust), Christopher P. Fox(University of Nottingham), Beth Stuart(Queen Mary University of London), Nicole Tipler(University of Southampton), David Goldblatt(Great Ormond Street Hospital), Adam G. Kelly(University of Southern California), Anna Bowzyk Al-Naeeb(Bedford Hospital), Graham P. Collins(Churchill Hospital), Ann O’Callaghan(Portsmouth Hospitals NHS Trust)
Cited by 16
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k